MEG3 and endometrial cancer: Together, these studies highlight the significant downregulation of MEG3 in endometrial cancer; its role in inhibiting cell proliferation, migration, and invasion; and its regulatory roles in modulating the Notch and PI3K pathways, thereby shedding light on potential therapeutic strategies for the treatment of endometrial cancer.